Epidemiology of Epstein—Barr Virus and Associated Diseases in Man

  • Guy De-Thé
Part of the The Viruses book series (VIRS)


This definition includes two main areas: (1) descriptive epidemiology, covering the distribution of diseases in place and time; and (2) analytical epidemiology, aimed at characterizing possible causal factors.


Nasopharyngeal Carcinoma Burkitt Lymphoma Infectious Mononucleosis Viral Capsid Antigen IARC Scientific Publication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adatia, A.K., 1970, Dental aspects, in: Buikitt’s Lymphoma (D.P. Burkitt and D.H. Wright, eds.), pp. 34–42, Livingstone, Edinburgh and London.Google Scholar
  2. Addy, P.A., Ahiabor, T., Amane, C, and Pappoe, M.A., 1978, Jaundice and infectious mononucleosis in Ghana, Afr. J. Med. Sci. 7(2):85–92.Google Scholar
  3. Al-Attar, A., Al-Mondhiry, H., Al-Bahrani, Z., and Al-Saleem, T., 1979, Burkitt’s lymphoma in Iraq: Clinical and pathological study of 47 patients, Int. J. Cancel 23:14–17.CrossRefGoogle Scholar
  4. Allison, A.C., and Clyde, D.F., 1961, Malaria in African Children with deficient erythrocyte glucose-6-phosphate dehydrogenase, Br. Med. J. 1:1346–1349.PubMedCrossRefGoogle Scholar
  5. American Joint Committee for Cancer Staging and End Results Reporting, 1976, Staging of Cancer at head and neck sites, in: Preliminary Handbook on Classification and Staging (Task Force on Head and Neck Sites, eds.), pp. 61–72, American Joint Committee, Chicago.Google Scholar
  6. Anderson, E.N., Jr., Anderson, M.L., and Ho, J.H.C., 1978, A study of the environmental backgrounds of young Chinese nasopharyngeal Carcinoma patients, 1978, in: Nasopharyngeal Carcinoma: Etiology and Control (G. de-Thé and Y. Ito, eds.), pp. 231–239, IARC Scientific Publication No. 20, World Health Organization, Geneva.Google Scholar
  7. Andiman, W.A., 1979, The Epstein-Barr virus and EBV infection in Childhood, J. Pediatr. 95:171–182.PubMedCrossRefGoogle Scholar
  8. Armstrong, D., Henle, G., and Henle, W., 1966, Complement-fixation tests with Cell lines derived from Burkitt’s lymphoma and acute leukemias, J. Bacteiiol 91:1257–1262.Google Scholar
  9. Armstrong, R.W., Kannan-Kutty, M., and Armstrong, M.J., 1978, Self-specific environments associated with nasopharyngeal Carcinoma in Selangor, Malaysia, Soc. Sci. Med. 12:149–156.PubMedCrossRefGoogle Scholar
  10. Arsenau, J.C., Canellos, G.P., Banks, P.M., Berard, CW., Granlick, H.R., and de-Vita, V.T., Jr., 1975, American Burkitt’s lymphoma: Clinicopathological study of thirty Cases. I. Clinical factors relating to prolonged survival, Am. J. Med. 58:314–321.CrossRefGoogle Scholar
  11. Bar, R.S., Delor, C.J., Clausen, K.P., Hurtubise, P., Henle, W., and Hewetson, J.F., 1974, Fatal infectious mononucleosis in a family, N. Engl. J. Med. 290:363–367.PubMedCrossRefGoogle Scholar
  12. Baron, D., Benz, W.C., Carmichael, G., Yocum, R.R., and Strominger, J.L., 1975, Assay and partial purification of Epstein-Barr nuclear antigen, in: Proceedings of the International Workshop on the Production, Concentration and Purification of Epstein-Barr Virus, pp. 257–262, IARC Press, Lyon.Google Scholar
  13. Bender, C.E., 1962, Recurrent mononucleosis, J. Am. Med. Assoc. 182:954–956.CrossRefGoogle Scholar
  14. Berard, C., O’Conor, G.T., Thomas, L.B., and Torloni, H., 1969, Histopathological definition of Burkitt’s tumor, Bull. WHO 40:601–607.Google Scholar
  15. Beremblum, I., 1940, The mechanisms of Carcinogenesis: A study of the significance of Cocarcinogenic action and related phenomena, Cancer Res. 1:807.Google Scholar
  16. Beremblum, I., 1978, Historical perspectives, in: CarcinogenesisA Comprehensive Survey, Vol. 2 (T.J. Slaga, A. Sivak, and R.K. Boutwell, eds.), p. 1, Raven Press, New York.Google Scholar
  17. Berger, R., Bernheim, A., Fellous, M., and Brouet, J.C., 1979a, Cytogenetic study of a,European Burkitt’s lymphoma Cell line, J. Natl. Cancer Inst. 62:1187–1192.PubMedGoogle Scholar
  18. Berger, R., Bernheim, A., Weh, H.J., Flandrin G., Daniel, M.T., Brouet, J.C., and Colbert, N., 1979b, A new translocation in Burkitt tumor cells, Hum. Genet. 53:111–112.PubMedCrossRefGoogle Scholar
  19. Berger, T., Bernheim, A., Flandrin, G., Daniel, M.T., Schaison, G., Brouet, J.C., and Bernard, J., 1979c, Translocation t(8; 14) dans la leucémie lymphoblastique de type Burkitt, Nouv. Presse Med. 8(3):181–183.PubMedGoogle Scholar
  20. Bernheim, A., Berger, R., and Lenoir, G., 1981, Cytogenetic studies on African Burkitt’s lymphoma Cell lines: t(8;14), t(2;8) and t(8;22) translocations, Cancer Genet. Cytogenet. 3:307–315.PubMedCrossRefGoogle Scholar
  21. Betuel, H., Cammoun, M., Colombani, J., Day, N., Ellouz, R., and de Thé, G., 1975, The relationship between nasopharyngeal Carcinoma and the HL-A system among Tunisians, Int. J. Cancer 16:249–254.PubMedCrossRefGoogle Scholar
  22. Biggar, R.J., and Nkrumah, F.K., 1979, Burkitt’s lymphoma in Ghana: Urban rural distribution, time-space Clustering and seasonality, Int. J. Cancer 23:330–336.PubMedCrossRefGoogle Scholar
  23. Biggar, R.J., Henle, W., Fleisher, G., Bocker, J., Lennette, E.T., and Henle, G., 1978a, Primary Epstein-Barr virus infection in African infants. I. Decline of maternal antibodies and time of infection, Int. J. Cancer 22:239–243.PubMedCrossRefGoogle Scholar
  24. Biggar, R.J., Henle, G., Bocker, S., Lennette, E.T., Fleisher, G., and Henle, W., 1978b, Primary Epstein-Barr virus infection in African infants. II. Clinical and serological observations during seroconversion, Int. J. Cancer 22:244–250.PubMedCrossRefGoogle Scholar
  25. Black, F.L., Woodall, J.P., Evans, A.S., Liebhaber, H., and Henle, G., 1970, Prevalence of antibody against viruses in Tiriyo, an isolated Amazon tribe, Am. J. Epidemiol, 91:430–438.PubMedGoogle Scholar
  26. Blot, W.J., Lanier, A., and Fraumeni, J.F., Jr., 1975, Cancer mortality among Alaskan natives, 1960–1969, J. Natl. Cancer Inst. 55:547–554.PubMedGoogle Scholar
  27. Bornkamm, G.W., Stein, H., Lennert, K., Rüggeberg, F., Bartels, H., and Zur Hausen, H., 1976, Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt’s lymphoma and immunoblastic lymphadenopathy with excessive plasmocytosis, Int. J. Cancer 17:177–181.PubMedCrossRefGoogle Scholar
  28. Britton, S., Andersson-Anvret, M, Gergely, P., Henle, W., Jonal, M., Klein, G., Sandstedt, B., and Svedmyr, E., 1978, Epstein-Barr virus immunity and tissue distribution in a fatal Case of infectious mononucleosis, N. Engl. J. Med. 298:89–92.PubMedCrossRefGoogle Scholar
  29. Brown, T.D.K., Ernberg, I., Lamon, E.W., and Klein, G., 1974, Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in human lymphoblastoid Cell lines by means of an I125-IgG-binding assay, Int. J. Cancer 13:784–794.CrossRefGoogle Scholar
  30. Brubaker, G., Geser, A., and Pike, M.C., 1973, Burkitt’s lymphoma in the North Mara district of Tanzania, 1964–1970: Failure to find evidence of space-time Clustering in a high risk isolated rural area, Br. J. Cancer 28:469–472.PubMedCrossRefGoogle Scholar
  31. Burchenal, J.H., 1966, Geographical Chemotherapy, Burkitt’s tumor as stalking horse for leukemia: Presidential address, Cancer Res. 26:2393–2405.PubMedGoogle Scholar
  32. Burkitt, D., 1958, A sarcoma involving the jaws in African Children, Br. J. Surg. 46:218.PubMedCrossRefGoogle Scholar
  33. Burkitt, D.P., 1962a, A Children’s Cancer dependent on Climatic factors, Nature (London) 194:232–234.CrossRefGoogle Scholar
  34. Burkitt, D.P., 1962b, A “tumor safari” in East and Central Africa, Br. J. Cancer 16:379–386.PubMedCrossRefGoogle Scholar
  35. Burkitt, D.P., 1967, Burkitt’s lymphoma outside the known endemic area of Africa and New Guinea, Int. J. Cancer 2:562–565.PubMedCrossRefGoogle Scholar
  36. Burkitt, D.P., 1969, Etiology of Burkitt’s lymphoma: An alternative to a vectored virus, J. Natl. Cancer. Inst. 42:19–28.PubMedGoogle Scholar
  37. Burkitt, D.P., 1970, Geographical distribution, in: Burkitt’s Lymphoma (D.P. Burkitt and D.H. Wright, eds.), pp. 186–197, Livingstone, Edinburgh and London.Google Scholar
  38. Burkitt, D.P., and Wright, D.H., 1966, Geographical and tribal distribution of the African lymphoma in Uganda, Br. Med.J. 5487:569–573.CrossRefGoogle Scholar
  39. Cammoun, M., Vogt-Hoerner, G., and Mourali, N., 1971, Les tumeurs du naso-pharynx en Tunisie: Etude anatomo-clinique de 143 observations, Tunis. Med. 49(3): 131–141.Google Scholar
  40. Carter, R.L., and Penman, H.G., 1969, Infectious Mononucleosis, Blackwell, Oxford.Google Scholar
  41. Carvalho, R.P.S., Evans, A.D., Forst, P., Dalldorf, G., Camargo, M.F., and Jamra, M., 1973, EBV infections in Brazil. I. Occurrence in normal persons, in lymphomas and in leukemias, Int. J. Cancer 11:191–201.Google Scholar
  42. Chan, S.H., Day, N.E., Khor, T.H., Kunaratnam, N., and Chia, K.B., HLA markers in the development and prognosis of NPC in Chinese, in: Cancer Campaign, Vol. 5, Nasopharyngeal Carcinoma (E. Grundmann, G.R.F. Krueger, and D.V. Ablashi, eds.) pp. 205–211, Gustav Fisher Verlag, Berlin.Google Scholar
  43. Chang, R.S., Lewis, J.S., Reynolds, R.D., Sullivan, M.J., and Neuman, J., 1978, Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts, Ann. Intern. Med. 88:111–123.Google Scholar
  44. Chang, R.S., Char, D.F., Jones, J.H., and Halstead, S.B., 1979, Incidence of infectious mononucleosis at the Universities of California and Hawaii, J. Infect. Dis. 140(4):479–86.PubMedCrossRefGoogle Scholar
  45. Cheeseman, S.H., Henle, W., Rubin, R.H., Tolkoff-Rubin, N.E., Cosimi, B., Cantell, K., Winkle, S., Herrin, J.T., Black, P.H., Russell, P.S., and Hirsch, M.S., 1980, Epstein-Barr virus infection in renal transplant recipients: Effects of antithymocyte globulin and interferon, Ann. Intern. Med. 93:39–42.PubMedGoogle Scholar
  46. Clifford, P., 1970a, A review on the epidemiology of nasopharyngeal Carcinoma, Int. J. Cancer 5:287–309.PubMedCrossRefGoogle Scholar
  47. Clifford, P., 1970b, Treatment, in: Burkitt’s lymphoma (D.P. Burkitt and D.H. Wright, eds.), pp. 52–63, Livingstone, Edinburg and London.Google Scholar
  48. Collected reports of Cases of Burkitt’s lymphoma from Countries outside the endemic areas, 1967, Int. J. Cancer 2:559–609.CrossRefGoogle Scholar
  49. Connelly, R.R., and Christine, B.W., 1974, A Cohort study of Cancer following infectious mononucleosis, Cancer Res. 34:1172–1178.PubMedGoogle Scholar
  50. Crawford, D.H., Epstein, M.A., Achong, B.G., Finerty, S., Newman, J., Liversedge, S., Tedder, R.S., and Steward, J.W., 1979, Virological and immunological studies on a fatal Case of infectious mononucleosis, J. Infection 1:37–48.CrossRefGoogle Scholar
  51. Crawford, D.H., Thomas, J.A., Janossy, G., Sweny, P., Fernando, O.N., Moorhead, J.F., and Thompson, J.H., 1980, Epstein-Barr virus nuclear antigen positive lymphoma after cyclosporin-A treatment in patient with renal allograft, Lancet: 1355–1356.Google Scholar
  52. Dalldorf, G., Linsell, C.A., Barnhart, F.E., and Martyn, R., 1964, An epidemiological approach to the lymphomas of African Children and Burkitt’s sarcoma of the jaws, Verspect. Biol. Med. 7:435–449.Google Scholar
  53. Dambaugh, T., Nkrumah, F.K., Biggar, R.J., and Kieff, E., 1979, Epstein-Barr virus RNA in Burkitt’s tumor tissue, Cell 16:313–322.PubMedCrossRefGoogle Scholar
  54. Dameshek, W., 1969, Speculations on the nature of infectious mononucleosis, in: Infectious Mononucleosis (R.L. Carter and H.G. Penman, eds.), pp. 225–240, Blackwell, London.Google Scholar
  55. Davidsohn, I., and Nelson, D.A., 1969, The blood, in: Todd-Sanfoid’s Clinical Diagnosis by Laboratory Methods, 14th ed. (I. Davidsohn and J.B. Henry, eds.), Chapt. 5, W.B. Saunders, Philadelphia.Google Scholar
  56. De Schryver, A., Friberg, S., Klein, G., Henle, W., Henle, G., de Thé, G., Clifford, P., and Ho, J.H.C., 1969, Epstein-Barr virus-associated antibody patterns in Carcinoma of the post-nasal space, Clin. Exp. Immunol. 5:443–459.PubMedGoogle Scholar
  57. Desgranges, C., and de-Thé, G., 1977, Epstein-Barr virus induces viral nuclear antigen in nasopharyngeal epithelial cells, Lancet 2:1286–1287.PubMedCrossRefGoogle Scholar
  58. Desgranges, C., and de-Thé, G., 1978a, Presence of EBV-specific IgA in saliva of nasopharyngeal Carcinoma (NPC) patients: Their activity, origin and possible Clinical value, in: Nasopharyngeal Carcinoma (G. de Thé and Y. Ito, eds.), pp. 459–469, IARC Scientific Publication No. 20, World Health Organization, Geneva.Google Scholar
  59. Desgranges, C., and de-Thé, G., 1978b, IgA and nasopharyngeal Carcinoma, in: Oncogenesis and Herpesviruses III (G. de Thé, Y. Ito, and F. Rapp, eds.), pp. 883–891, IARC Scientific Publication No. 25, Lyon.Google Scholar
  60. Desgranges, C., Wolf, H., de-Thé, G., Shanmugaratnam, K., Ellouz, R., Cammoun, N., Klein, G., and Zur Hausen, H., 1975a, Nasopharyngeal Carcinoma. X. Presence of Epstein-Barr genomes in epithelial cells of tumors from high and medium risk areas, Int. J. Cancer 16:7–15.PubMedCrossRefGoogle Scholar
  61. Desgranges, C., Wolf, H., Zur Hausen, H., and de-Thé, G., 1975b, Further studies on the detection of the Epstein-Barr viral DNA on nasopharyngeal Carcinoma biopsies from different parts of the world, in: Oncogenesis and Herpesviruses II, Vol. 2 (G. de Thé, M.A. Epstein, and H. Zur Hausen, eds.), pp. 191–193, IARC Scientific Publication No 11, Lyon.Google Scholar
  62. Desgranges, C., de-Thé, G., Ho, J.H.C., and Ellouz, R., 1977a, Neutralizing EBV-specific IgA in throat washings of nasopharyngeal Carcinoma (NPC) patients, Int. J. Cancer 19:627–633.PubMedCrossRefGoogle Scholar
  63. Desgranges, C., Li, J.Y., and de-Thé, G., 1977b, EBV specific secretory IgA in saliva of NPC patients: Presence of secretory piece in epithelial malignant cells, Int. J. Cancer 20:881–886.PubMedCrossRefGoogle Scholar
  64. Desgranges, C., Bornhamm, G.W., Zeng, Y., Wang, P.C., Zhu, J.S., Shang, H., and de-Thé, G., 1982, Detection of Epstein-Barr viral DNA in the nasopharyngeal mucosa of Chinese with IgA/EBV-specific antibodies, Int. J. Cancer 29:187–191.CrossRefGoogle Scholar
  65. de-Thé, G., 1977, Is Burkitt’s lymphoma related to a perinatal infection by Epstein-Barr virus?, Lancet 1:335–338.PubMedCrossRefGoogle Scholar
  66. de-Thé, G., 1978a, Epstein-Barr virus: Is it timely to discuss a vaccine?, Biomedicine 28:15–17.Google Scholar
  67. de-Thé, G., 1978b, Events early in life and risk to develop Burkitt’s lymphoma—Role of neonatal Epstein-Barr virus infection and heavy malaria burden, in: Tumors of Early Life in Man and Animals (L. Severi, ed.), pp. 225–231, Institute of Pathological Anatomy and Histology, Perugia.Google Scholar
  68. de-Thé, G., 1979, The epidemiology of Burkitt’s lymphoma: Evidence for a Causal relationship with Epstein-Barr virus, Am. J. Epidemiol. 1:32–54.Google Scholar
  69. de-Thé, G., 1980a, The role of the Epstein-Barr virus in human diseases: Infectious mononucleosis (IM), Burkitt’s lymphoma (BL) and nasopharyngeal Carcinoma (NPC), in: Viral Oncology (G. Klein, ed.), pp. 769–797, Raven Press, New York.Google Scholar
  70. de-Thé, G., 1980b, Multistep Carcinogenesis, Epstein-Barr virus and human malignancies: Viruses in naturally occurring Cancers, Cold Spring Harbor Conf. Cell Prolif. 7:11–21.Google Scholar
  71. de-Thé, G., 1981, The Chinese epidemiological approach of nasopharyngeal Carcinoma research and Control in China, Yale J. Biol. Med. 54:33–39.PubMedGoogle Scholar
  72. de-Thé, G., and Lenoir, G., 1977, Comparative diagnosis of Epstein-Barr virus related diseases: Infectious mononucleosis, Burkitt’s lymphoma and nasopharyngeal Carcinoma, in: Comparative Diagnosis of Viral Diseases (E. Kurstak, ed.), pp. 196–241, Academic Press, New York.Google Scholar
  73. de-Thé, G., and Zeng, Y., 1982, Epidemiology of EBV: Recent results on endemic versus nonendemic BL and EBV related pre-NPC Conditions, in Advances in Comparative Leukemia Research (D. Yohn and J.R. Blakeslee, eds.), pp. 3–15, Elsevier/North Holland, New York.Google Scholar
  74. de-Thé, G., Ablashi, D.V., Liabeuf, A., and Mourali, N., 1973a, Nasopharyngeal Carcinoma (NPC). VI. Presence of an EBV nuclear antigen in fresh tumor biopsies: Preliminary results, Biomedicine 19:349–352.PubMedGoogle Scholar
  75. de-Thé, G., Sohier, R., Ho, J.H.C., and Freund, R.J., 1973b, Nasopharyngeal Carcinoma. IV. Evolution of Complement-fixing antibodies during the Course of the disease, Int. J. Cancer 12:368–377.PubMedCrossRefGoogle Scholar
  76. de-Thé, G., Ho, J.H.C., Ablashi, D.V., Day, N.E., Macario, A.J.L., Martin-Bertholon, M.C., Pearson, G., and Sohier, R., 1975a, Nasopharyngeal Carcinoma. IX. Antibodies to EBNA and Correlation with response to other EBV antigens in Chinese patients, Int. J. Cancer 16:713–721.PubMedCrossRefGoogle Scholar
  77. de-Thé, G., Day, N.E., Geser, A., Lavoué, M.F., Ho, J.H.C., Simons, M.J., Sohier, R., Tukei, P., Vonka, V., and Zavadova, H., 1975b, Sero-epidemiology of the Epstein-Barr virus—Preliminary analysis of an international study, in: Oncogenesis and Herpesviruses II, Vol. 2 (G. de Thé, M.A. Epstein, and H. Zur Hausen, eds.), pp. 3–16, IARC Scientific Publication No. 11, Lyon.Google Scholar
  78. de-Thé, G., Vuillaume, M., Giovanella, B.C., and Klein, G., 1976, Epithelial Characteristics of tumor cells in nasopharyngeal Carcinoma (NPC) passaged in nude mice—an ultrastructural study, J. Natl. Cancer Inst. 57:1101–1105.PubMedGoogle Scholar
  79. de-Thé, G., Geser, A., Day, N.E., Tukei, P.M., Williams, E.H., Beri, D.P., Smith, P.G., Dean, A.G., Bornkamm, G.W., Feorino, P., and Henle, W., 1978a, Epidemiological evidence for a Causal relationship between Epstein-Barr virus and Burkitt’s lymphoma: Results of the Ugandan prospective study, Nature (London) 274:756–761.CrossRefGoogle Scholar
  80. de-Thé, G., Lavoué, M.F., and Muenz, L., 1978b, Differences in EBV antibody titers of patients with nasopharyngeal Carcinoma originating from high, intermediate and low incidence areas, in: Nasopharyngeal Carcinoma: Etiology and Control (G. De Thé and Y. Ito, eds.), pp. 471–481, IARC Press, Lyon.Google Scholar
  81. de-Thé, G., Desgranges, C., Zeng, Y., Wang, P.C., Bornkamm, G.W., Zhu, J.S., and Shang, M., 1981, Search for pre-cancerous lesions and EBV markers in the nasopharynx of IgA positive individuals, in: Cancer Campaign, Vol. 5, Nasopharyngeal Carcinoma (E. Grundmann, G.R.F. Krueger and D.V. Ablashi eds.), pp. 111–117, Gustav Fischer, Stuttgart.Google Scholar
  82. Diehl, V., Henle, W., and Kohn, G., 1968, Demonstration of a herpes group virus in Cultures of peripheral leukocytes from patients with infectious mononucleosis, J. Virol. 2:663–669.PubMedGoogle Scholar
  83. Durand-Fardel, 1837, Cancer du pharynx—ossification dans la substance musculaire du coeur, Bull. Soc. Anat. (Paris) 12:73–80.Google Scholar
  84. Ellouz, R., Cammoun, M., Ben-Altia, R., andBahi, J., 1978, NPC in Children and adolescents in Tunisia: Clinical aspects and paraneoplastic syndrome, in: Etiology and Control (G. de-Thé and Y. Ito, eds.), pp. 115–129, IARC Scientific Publication No. 20, Lyon.Google Scholar
  85. Epstein, M.A., 1976, Implications of a vaccine for the prevention of Epstein-Barr virus infection: Ethical and logistic Considerations, Cancer Res. 36:711–714.PubMedGoogle Scholar
  86. Epstein, M.A., 1981, What we Could do with an EBV vaccine, Lancet 1:759–761.Google Scholar
  87. Epstein, M.A., Achong, B.G., and Barr, Y.M., 1964, Virus particles in Cultured lymphoblasts from Burkitt’s lymphoma, Lan Cet 1:702–703.Google Scholar
  88. Epstein, M.A., Hunt, R.D., and Rabin, H., 1973, Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). I. Reticuloproliferative disease in an inoculated animal, Int. J. Cancer 12:309–318.PubMedCrossRefGoogle Scholar
  89. Evans, A.S., 1974, New discoveries in infectious mononucleosis, Mod. Med. 1:18–24.Google Scholar
  90. Evans, A.S., 1978, Infectious mononucleosis and related syndromes, IARC (Int. Agency Res. Cancer) Sci. Publ. 20:591–606.Google Scholar
  91. Evans, A.S., and Campos, L.E., 1971, Acute respiratory diseases in students at the University of the Philippines, Bull. WHO 45:103–112.PubMedGoogle Scholar
  92. Evans, A.S., and Niederman, J.C., 1976, Epstein-Barr virus, in: Viral Infections of Humans: Epidemiology and Control (A.S. Evans, ed.), pp. 209–234, Plenum Press, New York.CrossRefGoogle Scholar
  93. Evans, A.S., Niederman, J.C., and McCollum, R.W., 1968, Seroepidemiological studies of infectious mononucleosis with EB virus, N. Engl. J. Med. 297:1121–1127.CrossRefGoogle Scholar
  94. Fialkow, P.J., Klein, G., Gartier, S.M., and Clifford, P., 1970, Clonal origin for individual Burkitt tumors, Lancet 1:384–386.PubMedCrossRefGoogle Scholar
  95. Fong, Y.Y., and Chan, W.C., 1973, Bacterial production of di-methyl nitrosamine in salted fish, Nature (London) 243:421–423.CrossRefGoogle Scholar
  96. Fong, Y.Y., and Walsh, E.O., 1971, Carcinogenic nitrosamines in Cantonese salt-dried fish, Lancet 1:1032.CrossRefGoogle Scholar
  97. Fraumeni, J.F., Jr., and Mason, T.J., 1974, Cancer mortality among Chinese Americans, 1950–1969, J. Natl. Cancer Inst. 52:659–665.PubMedGoogle Scholar
  98. Gazzolo, L., de-Thé, G., and Vuillaume, M., 1972, Nasopharyngeal Carcinoma. II. Ultra-structure of normal mucosa tumor biopsies and subsequent epithelial growth in vitro,J. Natl. Cancer Inst. 48:73–86.PubMedGoogle Scholar
  99. Gerber, P., 1972, Activation of Epstein-Barr virus by 5-bromo-deoxyuridine in virus free human cells. Proc. Natl. Acad. Sci. U.S.A. 69:83–85.PubMedCrossRefGoogle Scholar
  100. Gerber, P., and Deal, D.R., 1970, Epstein-Barr virus-induced viral and soluble Complement-fixing antigens in Burkitt’s lymphoma Cell Cultures, Proc. Soc. Exp. Biol. Med. 134:748–751.PubMedGoogle Scholar
  101. Gerber, P., Purcell, R.H., Rosenblüm, E.N., and Walsh, J.H., 1969, Association of EB-virus infection with the post-perfusion syndrome, Lancet 1:593–596.PubMedCrossRefGoogle Scholar
  102. Gerber, P., Goldstein, L.L., Lucas, S., Nonoyama, M., and Perlin, E., 1972, Oral excretion of Epstein-Barr viruses by healthy subjects and patients with infectious mononucleosis, Lancet 2:988–989.PubMedCrossRefGoogle Scholar
  103. Geser, A., and de-Thé, G., 1972, Does the Epstein-Barr virus play an etiological role in Burkitt’s lymphoma?, in: Oncogenesis and Herpesviruses (V.M. Biggs, G. de Thé, and L.N. Payne, eds.), pp. 372–375, IARC Scientific Publication No. 2, Lyon.Google Scholar
  104. Geser, A., Charnay, N., Day, N.E., de-Thé, G., and Ho, J.H.C., 1978, Environmental factors in the etiology of nasopharyngeal Carcinoma: Report on a Case-control study in Hongkong, in: Nasopharyngeal Carcinoma: Etiology and Control (G. de Thé and Y. Ito, eds.), pp. 213–229, IARC Scientific Publication No. 20, Lyon.Google Scholar
  105. Geser, A., de-Thé, G., Lenoir, G., Day, N.E., and Williams, E.H., 1982, Final Case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt’s lymphoma. Int. J. Cancer 29:397–400.PubMedCrossRefGoogle Scholar
  106. Glaser, R., and Nonoyama, M., 1974, Host Cell regulation of induction of Epstein-Barr virus, J. Virol. 14:174–176.PubMedGoogle Scholar
  107. Glaser, R., and Rapp, F., 1972, Rescue of Epstein-Barr virus from somatic Cell hybrids of Burkitt lymphoblastoid cells, J. Virol. 10:288–296.PubMedGoogle Scholar
  108. Glaser, R., de-Thé, G., Lenoir, G., and Ho, J.H.C., 1976, Superinfection of nasopharyngeal Carcinoma epithelial tumor cells with Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 73:960–963.PubMedCrossRefGoogle Scholar
  109. Goldblum, N., Ben-Bassat, H., Mitrani, S., Andersson-Anvret, M., Goldblum, T., Aghai, E., Ramot, B., and Klein, G., 1977, A Case of an Epstein Barr virus genome-carrying lymphoma in an Israeli-Arab Child, Eur. J. Cancer 13:693–698.PubMedGoogle Scholar
  110. Goldstein, G., Klein, G., Pearson, G., and Clifford, P., 1969, Direct membrane immunofluorescence reaction of Burkitt’s lymphoma cells in culture, Cancer Res. 29:749–752.PubMedGoogle Scholar
  111. Granlund, D.J., and Andrese, A.P., 1977, Detection of Epstein-Barr virus antigen with enzyme-conjugated antibody, Int. J. Cancer 20:495–499.PubMedCrossRefGoogle Scholar
  112. Gravell, M.; Levine, P.H., Mclntyre, R.F., Land, V.J., and Pagano, J.S., 1976, EBV in an American patient with Burkitt’s lymphoma: Detection of viral genome in tumor tissue and establishment of a tumor derived Cell line, J. Natl. Cancer Inst. 56:701.PubMedGoogle Scholar
  113. Greene, M.H., Fraumeni, J.F., Jr., and Hoover, R., 1977, Nasopharyngeal Cancer among youths in United States: Racial variations by Cell type, J. Natl. Cancel Inst. 58:1267–1270.Google Scholar
  114. Greenwood, B.M., and Vick, R., 1975, Evidence for a malaria mitogen in human malaria, Nature (London) 257:592.CrossRefGoogle Scholar
  115. Greenwood, B.M., Oduloju, A.J., and Platts-Mill, T.A.E., 1979, Partial Characterization of a malaria mitogen, Trans. R. Soc. Trop. Med. Hyg. 73:178.PubMedCrossRefGoogle Scholar
  116. Gresser, I., and Tovey, M., 1978, Anti-tumor effects of interferon, Biochim. Biophys. Acta 516:231–247.PubMedGoogle Scholar
  117. Grose, C., and Feorino, P.M., 1972, Epstein-Barr virus and Guillain-Barré syndrome, Lancet 1:1285–1287.CrossRefGoogle Scholar
  118. Gross, L., 1970, Oncogenic Viruses, Pergamon Press, Oxford,Google Scholar
  119. Gu, S.Y., and Zeng, Y., 1978, Complement fixing antibody levels in sera from population groups in Kwangchow and in Peking, Chin. J. ENT, 1:23–25.Google Scholar
  120. Hallee, T.J., Evans, A.S., Niederman, J.C., Brooks, C.M., and Voegtly, J.H., 1974, Infectious mononucleosis as the U.S. Military Academy: A prospective study of a single Class over four years, Yale J. Biol. Med. 47:182–195.PubMedGoogle Scholar
  121. Hampar, B., Derge, J.G., Martos, L.M., and Walker, J.L., 1972, Synthesis of Epstein-Barr virus after the activation of the viral genome in a virus negative human lymphoblastoid cell (Raji) made resistant to five bromodeoxyuridine, Troc. Natl. Acad. Sci. U.S.A. 69:78–82.CrossRefGoogle Scholar
  122. Harada, M., Pearson, G., Redmon, L., Winters, E., and Kasuga, S., 1975, Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system, J. Immunol. 114:1318–1322.PubMedGoogle Scholar
  123. Hawkins, B.R., Simons, M.J., Goh, E.H., Chia, K.B., and Shanmugaratnam, K., 1974, Immunogenetic aspects of nasopharyngeal Carcinoma. II. Analysis of ABO, rhesus and MNS’s red Cell systems, Int. J. Cancer 13:116–121.PubMedCrossRefGoogle Scholar
  124. Heath, C.W., Brodsky, A.L., and Potolsky, A.I., 1972, Infectious mononucleosis in general population, Am. J. Epidemiol. 95:46–52.PubMedGoogle Scholar
  125. Hehlmann, R., Walther, B., Zöllner, N., Wolf, H., and Deinhardt, F., 1980, Infectious mononucleosis and acute monocytic leukaemia, Lancet:652–653.Google Scholar
  126. Henderson, B.E., Louie, E., Jing, J.S.H., Buell, P., and Gardner, M.B., 1976, Risk factors associated with nasopharyngeal Carcinoma, N. Engl. J. Med. 295:1101–1106.PubMedCrossRefGoogle Scholar
  127. Henle, G., and Henle, W., 1976, Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal Carcinoma, Int. J. Cancer 17:1–7.PubMedCrossRefGoogle Scholar
  128. Henle, G., Henle, W., and Diehl, V., 1968, Relation of Burkitt tumor associated herpes-type virus to infectious mononucleosis, Proc. Natl. Acad. Sci. U.S.A. 59:94–101.PubMedCrossRefGoogle Scholar
  129. Henle, G., Henle, W., Clifford, P., Diehl, V., Kafuko, G.W., Kirya, B.G., Klein, G., Morrow, R.H., Munube, G.M.R., Pike, P., Tukei, P.M., and Ziegler, J.L. 1969, Antibodies to Epstein-Barr virus in Burkitt’s lymphoma and Control groups, J. Natl. Cancer Inst. 43:1147–1157.PubMedGoogle Scholar
  130. Henle, G., Henle, W., Klein, G., Gunren, P., Clifford, P., Morrow, R., and Ziegler, J., 1971, Antibodies to early Epstein-Barr virus induced antigens in Burktt’s lymphoma, J. Natl. Cancer Inst. 46:861–871.PubMedGoogle Scholar
  131. Henle, G., Henle, W., and Horwitz, C.A., 1974, Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis, J. Infect. Dis. 130:231–239.PubMedCrossRefGoogle Scholar
  132. Henle, W., Henle, G., Harrison, F.S., Joyner, C.R., Klemola, E., Paloheimo, J., Scriba, M., and Von Essen, F., 1968, Antibody responses to the Epstein-Barr virus and Cytomegaloviruses after open-heart and other surgery, N. Engl. J. Med. 282:1068–1074.CrossRefGoogle Scholar
  133. Henle, W., Henle, G., Burtin, P., Cachin, Y., Clifford, P., de Schryver, A., de Thé, G., Diehl, V., Ho, J.H.C., and Klein, G., 1970a, Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms and Control groups, J. Natl. Cancer. Inst. 44:225–231.PubMedGoogle Scholar
  134. Henle, W., Henle, G., Zajac, B.A., Pearson, G., Waubke, R., and Scriba, M., 1970b, Differential reactivity of human serums with early antigens induced by Epstein-Barr virus, Science 169:188–190.PubMedCrossRefGoogle Scholar
  135. Henle, W., Ho, J.H.C., Henle, G., and Kwan, H.C., 1973, Antibodies to Epstein-Barr virus related antigens in nasopharyngeal Carcinoma: Comparison of active Cases and long term survivors, J. Natl. Cancer Inst. 51:361–369.PubMedGoogle Scholar
  136. Henle, W., Ho, J.H.C., Henle, G., Chan, J.C.W., and Kwan, H.C., 1977, Nasopharyngeal carcinoma: Significance of Changes in Epstein-Barr virus related antibody patterns following therapy, Int. J. Cancer 20:663–672.PubMedCrossRefGoogle Scholar
  137. Hewetson, J.F., Gothoskar, B., and Klein, G., 1972, Radioiodine-labelled antibody test for the detection of membrane antigens associated with Epstein-Barr virus, J. Natl. Cancer Inst. 48:87–94.PubMedGoogle Scholar
  138. Hirayama, T., 1978, Descriptive and analytical epidemiology of nasopharyngeal Cancer, in: Nasopharyngeal Carcinoma: Etiology and Control (G. de Thé and Y. Ito, eds.), pp. 167–190, IARC, Lyon.Google Scholar
  139. Hirshaut, Y., Cohen, M.H., and Stevens, D.A., 1973, Epstein-Barr virus antibodies in African and American Burkitt’s lymphomas, Lancet 1:114–116.CrossRefGoogle Scholar
  140. Ho, J.H.C., 1970, The natural history and treatment of nasopharyngeal Carcinoma (NPC), in: Oncology, Vol. 4 (R. Lee Clark, R. Cumley, f.E. McCay, and M. Copeland, eds.), pp. 1–14, Medical Publishers, Year Book, Chicago.Google Scholar
  141. Ho, J.H.C., 1971, Incidence of nasopharyngeal Cancer in Hongkong, UICC Bulletin, Cancer 9(2):5.Google Scholar
  142. Ho, J.H.C., 1972a, Current knowledge of the epidemiology of nasopharyngeal Carcinoma: A review, in: Oncogenesis and Herpesviruses (P. Biggs, de Thé, and L. Payne, eds.), pp. 357–366, IARC, Lyon.Google Scholar
  143. Ho, J.H.C., 1972b, Nasopharyngeal Carcinoma (NPC), in: Advances in Cancer Research (G. Klein, S. Weinhouse, and A. Haddow, eds.), pp. 59–92, Academic Press, New York.Google Scholar
  144. Ho, J.H.C., 1978, An epidemiologic and Clinical study of nasopharyngeal Carcinoma, Int. J. Radiol. Oncol. Biol. Phys. 4:181–198.Google Scholar
  145. Ho, J.H.C., Ng, M.H., Kwan, H.C., and Chan, J.C.W., 1976, Epstein-Barr virus specific IgA and IgG serum antibodies in nasopharyngeal Carcinoma, Br. J. Cancer 34:655–660.PubMedCrossRefGoogle Scholar
  146. Ho, J.H.C., Kwan, H.C., Ng, M.H., and de-Thé, G., 1978, Serum IgA antibodies to EBV Capsid antigens preceeding symptoms of nasopharyngeal Carcinoma, Lancet 1:436–437.PubMedCrossRefGoogle Scholar
  147. Ho, J.H.C., Lau, W.H., Kwan, H.C., Chan, C.L., Au, G.K.H., Saw, D., and De Thé, G., 1981, Diagnostic and prognostic serological markers in nasopharyngeal Carcinoma, in: Cancer Campaign, Vol. 5, Nasopharyngeal Carcinoma, (E. Grundmann, G.R.F. Krueger, and D.V. Ablashi, eds.), pp. 219–224, Gustav Fischer, Stuttgart.Google Scholar
  148. Hoogstraten, f., 1967, Observations on Burkitt’s tumor in Central and northern Canada, Int. J. Cancer 2:566–575.PubMedCrossRefGoogle Scholar
  149. Huang, D.P., Ho, J.H.C., Henle, W., and Henle, G., 1974, Demonstration of Epstein-Barr virus associated nuclear antigen in nasopharyngeal Carcinoma cells from fresh biopsies, Int. J. Cancer 14:580–588.PubMedCrossRefGoogle Scholar
  150. Huang, D.P., Ho, J.H.C., Saw, D., and Teoh, T.B., 1978, Carcinoma of the nasal and paranasal regions in rats fed Cantonese salted marine fish, in: Nasopharyngeal Carcinoma: Etiology and Control (G. de Thé and Y. Ito, eds.), pp. 315–328, IARC, Lyon.Google Scholar
  151. Huebner, R.J., 1957, The virologist’s dilemma, Ann. N Y. Acad. Sci. 67:430.PubMedCrossRefGoogle Scholar
  152. Huebner, R.J., and Todaro, G.J., 1969, Oncogenes of RNA tumor viruses as determinants of Cancer, Proc. Natl. Acad. Sci. U.S.A. 64:1087.PubMedCrossRefGoogle Scholar
  153. International Agency for Research on Cancer (IARC), Annual Report, 1968, Internal Technical Report Series 68/004, Planning Conference for epidemiological studies on Burkitt’s lymphoma and infectious mononucleosis, Nairobi, Kenya, p. 35.Google Scholar
  154. International Agency for Research on Cancer, Annual Report, 1976, WHO Publications, Geneva.Google Scholar
  155. International Agency for Research on Cancer, Annual Report, 1978, WHO Publications, Geneva.Google Scholar
  156. International Agency for Research on Cancer, Annual Report, 1980, WHO Publications, Geneva.Google Scholar
  157. Ito, Y., Kawanishi, M., Hirayama, T., and Takabayashi, S., 1981, Combined effect of the extracts from Croton Tiglium, Euphorbia lathyhs or Euphorbia tizucalli and N-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells, Cancer Lett 12:175–180.PubMedCrossRefGoogle Scholar
  158. Jarrett, W.F.H., McNeil, P.E., Laird, H.M., O’Neil, B.W., Murphy, J., Campo, M.S., and Moar, M.H., 1980, Papilloma viruses in benign and malignant tumors of Cattle, in: Viruses in Naturally Occurring Cancers (M. Essex, G. Todaro, H. Zur Hausen, eds.), Cold Spring Harbor Conf. Cell Prolif. 7:215–222.Google Scholar
  159. Jarvis, J.E., Ball, G., and Rickinson, A.B., 1974, Cytogenetic studies on human lymphoblastoid Cell lines from Burkitt’s lymphoma and other sources, Int. J. Cancer 14:716.PubMedCrossRefGoogle Scholar
  160. Jennings, E., M.D. thesis, 1973, Yale School of Medicine.Google Scholar
  161. Jondal, M., 1976, Antibody-dependent Cellular Cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis, Clin. Exp. Immunol. 25:1–5.PubMedGoogle Scholar
  162. Judson, S.C., Henle, W., and Henle, G., 1977, A Cluster of Epstein-Barr virus associated American Burkitt’s lymphoma, N. Engl. J. Med. 297:464–468.PubMedCrossRefGoogle Scholar
  163. Kafuko, G.W., Henderson, B.E., Kirya, G.G., Manube, G.M., Tukei, P., Day, N.E., Henle, G., Henle, W., Morrow, R.H., Pike, M.C., Smith, P.G., and Williams, E. H., 1972, Epstein-Barr virus antibody levels in Children from the West Nile district of Uganda: Report of a field study, Lancet 1:706–709.PubMedCrossRefGoogle Scholar
  164. King, H., and Haenszel, 1972, Cancer mortality among foreign and native-born Chinese in the United States, J. Chron. Dis. 26:623–646.CrossRefGoogle Scholar
  165. Kirk, R.L., Blake, N.M., Serjeantson, S., Simons, M.J., and Chan, S.H., 1978, Genetic Components in susceptibility to nasopharyngeal Carcinoma, in: Nasopharyngeal Carcinoma: Etiology and Control (G. de Thé and Y. Ito, eds.), pp. 283–297, IARC Scientific Publication No. 20, Lyon.Google Scholar
  166. Klein, G., 1979, Lymphoma development in mice and humans: Diversity of initiation is followed by a Convergent Cytogenetic evolution, Proc. Natl. Acad. Sci. U.S.A. 76:2442.PubMedCrossRefGoogle Scholar
  167. Klein, G., Clifford, P., Klein, E., Smith, R.T., Minowada, J., Kourilski, F.M., and Burchenal, J.H., 1967, Membrane immunofluorescence reactions of Burkitt’s lymphoma cells from biopsy specimens and tissue Culture, J. Natl. Cancer Inst. 39:1027–1044..PubMedGoogle Scholar
  168. Klein, G., Pearson, G., Nadkarni, J.S., Nadkarni, J.J., Klein, E., Henle, G., Henle, W., and Clifford, P., 1968, Relation between Epstein-Barr viral and Cell membrane immunofluorescence of Burkitt tumor Cells. I. Dependence of Cell membrane immunofluorescence on presence of EB virus, J. Exp. Med. 128:1011–1020.PubMedCrossRefGoogle Scholar
  169. Klein, G., Pearson, G., Henle, G., Henle, W., Goldstein, G., and Clifford, P., 1969, Relation between Epstein-Barr viral and Cell membrane immunofluorescence in Burkitt tumor Cells. III. Comparison of blocking of direct membrane immunoflurescence and anti-EBV reactivities of different sera, J. Exp. Med. 129:697–705.PubMedCrossRefGoogle Scholar
  170. Klein, G., Giovanella, B.C., Lindahl, T., Fialkow, P.J., Singh, S.; and Stehlin, J., 1974, Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with anaplastic Carcinoma of the nasopharynx, Proc. Natl. Acad. Sci. U.S.A. 71:4737–4741.PubMedCrossRefGoogle Scholar
  171. Koch, R., 1980, Über bakteriologische Forschung, in: Verh. X. Int. Med. Congr. Berlin, 35.Google Scholar
  172. Kvale, G., Holby, E.A., and Pedersen, E., 1979, Hodgkin’s disease in patients with previous infectious mononucleosis, Int. J. Cancer 23(5):593–597.PubMedCrossRefGoogle Scholar
  173. Lachet, B., Day, N.E., de-Thé, G., and Dufour, f., 1977, Temps de latence du lymphôme de Burkitt en Ouganda, Med. Biol. Environ. 5:60–67.Google Scholar
  174. Lang, D.J., Garruto, R.M., and Gajdusek, D.C., 1977, Early acquisition of Cytomegalovirus and Epstein-Barr virus antibody in several isolated Melanesian populations, Am. J. Epidemiol. 105:480–487.PubMedGoogle Scholar
  175. Lange, B., Arbeter, A., Hewetson, J., and Henle, W., 1978, Longitudinal study of Epstein-Barr virus antibody titers and excretion in pediatric patients with Hodgkin’s disease, Int. J. Cancer 22(5):521–527.PubMedCrossRefGoogle Scholar
  176. Lanier, A.P., Henle, W., Bender, T.R., Henle, G., and Talbot, M.L., 1980a, Epstein-Barr virus-specific antibody titers in seven Alaskan natives before and after diagnosis of nasopharyngeal Carcinoma, Int. J. Cancel 26:133–137.CrossRefGoogle Scholar
  177. Lanier, A.P., Bender, T., Talbot, M., Wilmeth, S., Tschopp, C., Henle, W., Henle, G., Ritter, D., and Terasaki, P., 1980b, Nasopharyngeal Carcinoma in Alaskan Eskimos, Indians and Aleuts: A review of Cases and study of Epstein-Barr virus, HLA and environmental risk factors, Cancer 46(9):2100–2006.PubMedCrossRefGoogle Scholar
  178. Lenoir, G., Philip, T., Bornkamm, G.W., Gillet, P., Bryon, P.A., Bouvier, R., Dodat, H., Dore, J.F., Burnat-Mentigny, M., and Hermier, M., 1979, Lymphome de Burkitt associé au virus d’Epstein-Barr Chez un enfant français, Nouv. Presse Med. 49:4031–4034.Google Scholar
  179. Levine, P.H., O’Conor, G.T., and Berard, C.W., 1972, Antibodies to Epstein-Barr virus in American patients with Burkitt’s lymphoma, Cancer 30:610–615.PubMedCrossRefGoogle Scholar
  180. Levine, P.H., Cho, B.R., Connelly, R.R., Berard, C.W., O’Conor, C.T., Dorfman, R.F., Easton, J.M., and de Vita, V.T., 1975, The American Burkitt’s Lymphoma Registry: A progress report, Ann. Intern. Med. 83:31–36.PubMedGoogle Scholar
  181. Liang, P.C., 1964, Studies on nasopharyngeal Carcinoma in Chinese: Statistical and laboratory investigations, Chin. Med. J. 83:373–390.PubMedGoogle Scholar
  182. Lin, T.M., Chen, K.P., Lin, C.C., Hsu, M.M., Tu, S.M., Chiang, T.C., Jung, P.F., and Hirayama, T., 1975, Retrospective study on nasopharyngeal Carcinoma, J. Natl. Cancer Inst. 51:1403–1408.Google Scholar
  183. Lindahl, T., Klein, G., Reedman, B.M., Johansson, B., and Singh, S., 1974, Relationship between Epstein-Barr virus DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt’s lymphoma biopsies and other lympho-proliferative malignancies, Int. J. Cancer 13:764–772.PubMedCrossRefGoogle Scholar
  184. Liu, Y.X., and Zeng, Y., 1979, Detection of EB-virus specific IgA antibody from patients with NPC by immunoenzymatic method, Chin. J. Oncol. 1:8.Google Scholar
  185. Lopez, C., Watanabe, K.A., and Fox, J.J., 1980, 2’-Fluoro-5-iodo-aracytosine, a potential and selective anti-herpesvirus agent, Antimicrob. Agents Chemother. 17:803–806.PubMedGoogle Scholar
  186. Manolov, G., and Manolova, Y., 1972, Marker bank in one Chromosome 14 from Burkitt’s lymphomas, Nature (London) 237:33.CrossRefGoogle Scholar
  187. Marker, S.C., Ascher, N.L., Kalis, J.M., Simmons, R.L., Najarian, J.S., and Balfour, H.H., Jr., 1979, Epstein-Barr virus antibody responses and Clinical illness in renal transplant recipients, Surgery 85(4):433–440.PubMedGoogle Scholar
  188. Mathew, G.D., Qualtière, L.F., Neel, H.B., III, and Pearson, G.R., 1981, IgA antibody, antibody-dependent-cellular-cytoxicity and prognosis in patients with nasopharyngeal carcinoma, Int. J. Cancer 27:175–180.PubMedCrossRefGoogle Scholar
  189. Matsuo, T., Nishi, S., Hirasi, H., and Osato, T., 1976, Studies on Epstein-Barr virus-related antigens. I. Indirect single-radial immunodiffusion as a useful method for detection and assay of soluble antigen, Int. J. Cancer 18:453–457.PubMedCrossRefGoogle Scholar
  190. McCaw, B.K., Epstein, A.L., Kaplan, H.S., and Hecht, F., 1977, Chromosome 14 translocation in African and North American Burkitt’s lymphoma, Int. J. Cancer 19:482–486.CrossRefGoogle Scholar
  191. Michaux, L., 1944, Carcinome de base du Crâne, Cited in Godtfredson (19). Ophthalmologic and neurologic symptoms at malignant nasopharyngeal tumors: Clinical study Comprising 454 Cases, with special reference to histopathology and possibility of earlier recognition, Acta Psychiatr. Scand. Suppl. 34:1–323.Google Scholar
  192. Micheau, C., de-Thé, G., Orofiamma, B., Schwaab, G., Brugère J., Tursz, T., Sancho-Garnier, H., and Cachin, Y., 1980, Carcinomas of the nasopharynx: Relationship between histological type and anti-Epstein-Barr virus serology, Nouv. Presse Med. 9(1):21–24.PubMedGoogle Scholar
  193. Micheau, C., de-Thé, G., Orofiamma, B., Schwaab, G., Brugère, J., Tursz, T., Sancho-Garnier, H., and Cachin, Y., 1981, Practical value of Classifying nasopharyngeal Carcinoma in two major microscopical types, in: Cancer Campaign, Vol. 5, Nasopharyngeal Carcinoma (E. Grundmann, G.R.F. Krueger, and D.V. Ablashi, eds.), pp. 51–57, Gustav Fischer, Stuttgart.Google Scholar
  194. Miller, G., and Beebe, G.W., 1973, Infectious mononucleosis and the empirical risk of Cancer, J. Natl. Cancer Inst 50:315–321.PubMedGoogle Scholar
  195. Miller, G., Niederman, J.C., and Stitt, D.A., 1972a, Infectious mononucleosis: Appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid Cell lines, J. Infect. Dis. 125:403–406.PubMedCrossRefGoogle Scholar
  196. Miller, G., Shope, T., Lisco, H., Stitt, D., and Lipman, M., 1972b, Epstein-Barr virus: Transformation, Cytopathic Changes and viral antigens in squirrel monkey and marmoset leukocytes, Proc. Natl. Acad. Sci. U.S.A. 69:383–387.PubMedCrossRefGoogle Scholar
  197. Miller, G., Niederman, J.C., and Andrews, L.L., 1973, Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis, N. Engl. J. Med. 188:229–232.CrossRefGoogle Scholar
  198. Miller, G., Shope, T., and Coope, D., 1974, Aspects of the pathogenesis of lymphoma in cotton-top marmosets following inoculation of EB virus, in: Mechanisms of Virus Diseases, Vol. 1 (W.S. Robinson and F.C. Fox, eds.), pp. 429–454, W.A. Benjamin, Menlo Park, California.Google Scholar
  199. Mitelman, F., Andersson-Anvret, M., Brandt, L., Catovsky, D., Klein, G., Manolov, G., Manolova, Y., Mark-Vendel, E., and Nilsson, P.G., 1979, Reciprocal 8; 14 translocation in EBV-negative B-cell acute lymphocytic leukemia with Burkitt type cells, Int. J. Cancer 24:27–33.PubMedCrossRefGoogle Scholar
  200. Miyamoto, K., Miyano, K., Miyoshi, I., Hamasaki, K., Nishihara, R., Terao, S., Kimura, I, Maeda, K., Matsumara, K., Nishijima, K., and Tanaka, T., 1980, Chromosome 14q+ in a Japanese patient with Burkitt’s lymphoma, Acta Med. Okayama 34:61–65.PubMedGoogle Scholar
  201. Miyoshi, I., Hiraki, S., Tsubota, T., Uno, J., Nakamura, K., Ota, T., Hikita, T., Hayashi, K., Kataoka, M., Tanaka, T., Kimura, I., and Sairenui Hinuma, Y., 1978, Epstein-Barr virus positive Japanese Burkitt lymphoma, Gann 69:449–450.PubMedGoogle Scholar
  202. Miyoshi, I., Hiraki, S., Kimura, I., Miyamoto, K., and Sato, J., 1979, 2/8 translocation in a Japanese Burkitt’s lymphoma, Experientia 35:742–743.PubMedCrossRefGoogle Scholar
  203. Moar, M.H., Siegert, W., and Klein, G., 1977, Detection and localization of Epstein-Barr virus associated early antigens in single cells by autoradiography using I125 labelled antibodies, Intervirology 8:226–239.PubMedCrossRefGoogle Scholar
  204. Morgan, D.G., Miller, G., Niederman, J.C., Smith, H.W., and Dowaliby, J.M., 1979, Site of Epstein-Barr virus replication in the oropharynx, Lancet:1154–1157.Google Scholar
  205. Morrow, R.H., Kisuule, A., Pike, M.C., and Smith, P., 1976, Burkitt’s lymphoma in the Mengo districts of Uganda: Epidemiologic features and their relationship to malaria, J. Natl. Cancer Inst. 56:479–483.PubMedGoogle Scholar
  206. Morrow, R.H., Pike, M.C., and Smith, P.G., 1977, Further studies of space-time Clustering of Burkitt’s lymphoma in Uganda, Br. J. Cancer 35:668–673.PubMedCrossRefGoogle Scholar
  207. Motulsky, A.G., 1964, Hereditary red Cell traits and malaria, Am. J. Trop. Med. Hyg. 13:147–158.PubMedGoogle Scholar
  208. Muir, C.S., 1972, Nasopharyngeal Carcinoma in non-Chinese populations, in: Oncogenesis and Herpeviruses (P.M. Biggs, G. de Thé, and L.N. Payne, eds.), pp. 367–371, IARC, Lyon.Google Scholar
  209. Munoz, N., Davidson, R.J., Witthoff, B., Ericsson, J.E., and de-Thé, G., 1978, Infectious mononucleosis and Hodgkin’s disease, Int. J. Cancer 22:10–13.PubMedCrossRefGoogle Scholar
  210. National Office for Cancer Control, China’s Ministry of Health, and the Nanjing Institute of Geography, Chinese Academy of Medical Sciences, 1981, Atlas of Cancer Mortality in the People’s Republic of China (Dr. LiPing) (in press).Google Scholar
  211. Niederman, J.C., McCollum, R.W., Henle, G., and Henle, W., 1968, Infectious mononucleosis: Clinical manifestations in relation to Epstein-Barr virus antibodies, J. Am. Med. Assoc. 203:205–209.CrossRefGoogle Scholar
  212. Nielsen, N.H., Mikkelsen, F., and Hansen, J.P., 1977, Nasopharyngeal Cancer in Greenland, Acta Pathol. Microbiol. Scand. 85(6):850–858.Google Scholar
  213. Nkrumah, F.K., and Perkins, I.V., 1976, Sickle Cell trait, hemoglobin C trait and Burkitt’s lymphoma, Am. J. Trop. Med. Hyg. 25:633–636.PubMedGoogle Scholar
  214. Nkrumah, F.K., Perkins, I.V., and Biggar, R.J., 1977, Combination Chemotherapy in abdominal Burkitt’s lymphoma, Cancer 40:1410–1416.PubMedCrossRefGoogle Scholar
  215. Nonoyama, M., and Pagano, J.S. 1973, Homology between Epstein-Barr viruses DNA and viral DNA from Burkitt’s lymphoma and nasopharyngeal Carcinoma determined by DNA-DNA reassociation kinetics, Nature (London) 242:44–47.CrossRefGoogle Scholar
  216. Nonoyama, M., Huang, D.P., Pagano, J.S., Klein, G., and Singh, S., 1973, DNA of Epstein-Barr virus detected in tissue of Burkitt’s lymphoma and nasopharyngeal Carcinoma, Proc. Natl Acad. Sci. U.S.A. 70:3265–3268.PubMedCrossRefGoogle Scholar
  217. O’Conor, G.T., 1961, Malignant lymphoma in African Children. II. A pathological entity, Cancer 12:270–283.CrossRefGoogle Scholar
  218. O’Conor, G.T., 1970, Persistent immunologic stimulation as a factor in oncogenesis with special reference to Burkitt’s tumor, Am. J. Med. 48:279–285.CrossRefGoogle Scholar
  219. O’Conor, G.T., and Davies, J.N.P., 1960, Malignant tumors in African Children with special reference to malignant lymphoma, J. Pediatr. 56:526–535.PubMedCrossRefGoogle Scholar
  220. Old, L.J., Clifford, P., Boyse, E.A., de Harven, E., Geering, G., Oettgen, H.F., and Williamson, B., 1966, Precipitating antibody in human serum to an antigen present in Cultured Burkitt lymphoma cells, Proc. Natl. Acad. Sci. U.S.A. 56:1699–1704.PubMedCrossRefGoogle Scholar
  221. Olweny, CL.M., Atine, I., Kaddu-Mukasa, A., Owor, R., Anderson, M., Klein, G., Henle, W., and de Thé, G., 1977, Epstein-Barr virus genome studies in Burkitt and non-Burkitt lymphomas in Uganda, J. Natl. Cancer Inst. 58:1191–1196.PubMedGoogle Scholar
  222. Olweny, CL.M., Katongole-Mbidde, E., Otim, D., Lwanga, S.K., Magrath, LT., and Ziegler, J.L., 1980, Long term experience with Burkitt’s lymphoma in Uganda, Int. J. Cancer 26:261–266.PubMedCrossRefGoogle Scholar
  223. Orofiamma, B., Micheau, C., Schwaab, G., Sancho-Garnier, H., de-Thé, G., and Brugère, J., 1982, Carcinomes du rhinopharynx: Relations entre types histologiques et Caractéristiques étio-épidémiologiques, Nouv. Presse Med. (submitted).Google Scholar
  224. Pagano, J.S., Huang, D.H., and Levine, P., 1973, Absence of Epstein-Barr viral DNA in American Burkitt’s lymphoma, N. Engl. J. Med. 289:1395–1399.PubMedCrossRefGoogle Scholar
  225. Paul, J.R., and Bunnell, W.W., 1932, The presence of heterophile antibodies in infectious mononucleosis, Am. J. Med. Sci. 183:91–104.CrossRefGoogle Scholar
  226. Pearson, G.R., and Orr, T.W., 1976, Antibody-dependent lymphocyte-cytotoxicity against cells expressing Epstein-Barr virus antigens, J. Natl. Cancer Inst. 56:485–488.PubMedGoogle Scholar
  227. Pearson, G.R., and Qualtière, L.F., 1978, Papain solubilization of the Epstein-Barr virus-induced membrane antigen, J. Virol. 28:344–351.PubMedGoogle Scholar
  228. Pearson, G.R., and Scott, R.E., 1978, Potential for immunization against herpesvirus infection with plasma membrane vesicles, in: Oncogenesis and Herpesviruses III (G. de Thé, W. Henle, and F. Rapp, eds.), pp. 1019–1025, IARC Scientific Publication No. 24, Lyon.Google Scholar
  229. Pearson, G.R., Dewey, F., Klein, G., Henle, G., and Henle, W., 1970, Relation between neutralization of Epstein-Barr virus and antibodies to Cell membrane antigens induced by the virus, J. Natl. Cancer Inst. 45:989–995.PubMedGoogle Scholar
  230. Pearson, G.R., Prevost, J.M., and Orr, T.W., 1975, Detection of virus-associated antigens with the antibody-dependent lymphocyte Cytotoxicity test, in: Proceedings of the International Workshop on the Production, Concentration and Purification of Epstein-Barr Virus, pp. 263–275, IARC, Lyon.Google Scholar
  231. Pearson, G.R., Johansson, B., and Klein, G., 1978a, Antibody-dependent Cellular Cytotoxicity against Epstein-Barr virus associated antigens in African patients with nasopharyngeal Carcinoma, Int. J. Cancer 22:120–125.PubMedCrossRefGoogle Scholar
  232. Pearson, G.R., Coates, H.L., Needl, H.B., Levine, P., Ablashi, D., and Easton, J., 1978b, Clinical evaluation of EBV serology in American patients with nasopharyngeal Carcinoma, in: Nasopharyngeal Carcinoma: Etiology and Control (G. de Thé and Y. Ito, eds.), pp. 439–448, IARC, Lyon.Google Scholar
  233. Pearson, G.R., Qualtière, L.F., Klein, G., Norin, T., and Bal, I.S., 1979, Epstein-Barr virus-specific antibody-dependent Cellular Cytotoxicity in patients with Burkitt’s lymphoma, Int. J. Cancer 24:402–406.PubMedCrossRefGoogle Scholar
  234. Peto, R., 1977, Epidemiology, multistage models and short-term mutagenicity tests, Cold Spring Harbor Conf. Cell Prolif. 4:1403.Google Scholar
  235. Pfeiffer, E., 1889, Drüsenfieber, Jahrb. Kinderheilkd. 29:257–264.Google Scholar
  236. Pickens, S., and Murdoch, J.M., 1979, Infectious mononucleosis in the elderly, Age Ageing 8(2):93–95.PubMedCrossRefGoogle Scholar
  237. Pike, M.C., Williams, E.H., and Wright, B., 1967, Burkitt’s tumor in the West Nile district of Uganda, 1961–1965, Br. Med. J. 2:395–399.PubMedCrossRefGoogle Scholar
  238. Pike, M.C., Morrow, M.D., Kisuule, A., and Mafigiri, J., 1970, Burkitt’s lymphoma and sickle Cell trait in Uganda, Br. J. Prev. Soc. Med. 24:39–41.PubMedGoogle Scholar
  239. Pope, J.H., Horne, M.K., and Scott, W., 1969a, Identification of the filtrable leucocyte transforming factor of QIMR-WILL cells as herpesvirus, Int. J. Cancer 4:255–260.PubMedCrossRefGoogle Scholar
  240. Pope, J.H., Horne, M.K., and Wetters, E.J., 1969b, Significance of a Complement-fixing antigen associated with herpes-like virus and detected in the Raji Cell line, Nature (London) 222:166–167.CrossRefGoogle Scholar
  241. Prather, S.O., and Lausch, R.N., 1976, Kinetics of serum factors mediating blocking, unblocking and antibody-dependent Cellular Cytotoxicity in hamsters given isografts of Para-7 tumor cells, Int. J. Cancer 17:380–388.PubMedCrossRefGoogle Scholar
  242. Purtilo, D.T., 1980, Registry of fatal infectious mononucleosis and Epstein-Barr virus infections, J. Am. Med. Assoc. 243(18):1806.CrossRefGoogle Scholar
  243. Purtilo, D.T., Cassel, C.K., Yang, J.P.S., Harper, R., Stephenson, S.R., Landing, B.H., and Vawter, G.F., 1975, X-linked recessive progressive Combined variable immunodeficiency (Duncan’s disease), Lancet 1:937–941.Google Scholar
  244. Purtilo, D.T., Paquin, L., DeFlorio, D., Virzi, F., and Sakhuia, R., 1979, Immunodiagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome, Semin. Hematol. 16:309–343.PubMedGoogle Scholar
  245. Reedman, B.M., and Klein, G., 1973, Cellular localization of an Epstein-Barr virus (EBV) associated Complement-fixing antigen in producer and non-producer lymphoblastoid Cell lines, Int. J. Cancer 2:499–520.CrossRefGoogle Scholar
  246. Reedman, B.M., Klein, G., Pope, J.H., Walters, M.K., Hilgers, J., Singh, S., and Johansson, B., 1974, Epstein-Barr virus associated Complement fixing and nuclear antigens in Burkitt’s lymphoma biopsies, Int. J. Cancer 13:755–763.PubMedCrossRefGoogle Scholar
  247. Rickinson, A.B., Jarvis, J.E., Crawford, D.H., and Epstein, M.A., 1974, Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis, Int. J. Cancer 14:704–715.PubMedCrossRefGoogle Scholar
  248. Rivers, T., 1937, Viruses and Koch’s postulates, J. Bacteriol. 33:1–12.PubMedGoogle Scholar
  249. Robinson, J.E., Brown, N., Andiman, W., Halliday, K., Francke, U., Robert, M.F., Andersson-Anvret, M., Horstmann, D., and Miller, G., 1980, Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus, N. Engl. J. Med. 302:1293–1297.PubMedCrossRefGoogle Scholar
  250. Rocchi, G., Hewetson, J., and Henle, W., 1973a, Specific neutralizing antibodies in Epstein-Barr virus-associated diseases, Int. J. Cancer 11:637–647.PubMedCrossRefGoogle Scholar
  251. Rocchi, G., Hewetson, J., Henle, W., and Henle, G., 1973b, Antigen expression and Colony formation of lymphoblastoid Cell lines after superinfection with Epstein-Barr virus, J. Natl. Cancer Inst. 50:307–314.PubMedGoogle Scholar
  252. Rosdahl, N., Larsen, S.O., and Clemmesen, J., 1974, Hodgkin’s disease in patients with previous infectious mononucleosis: 30 years’ experience, Br. Med. J. 2:253–256.PubMedCrossRefGoogle Scholar
  253. Saad, A., 1968, Observations on nasopharyngeal Carcinoma in the Sudan, in: Cancer in Africa (C.A. Linsell and G.L. Limms, eds.), pp. 281–285, East African Publishing House, Nairobi.Google Scholar
  254. Saemundsen, E., Berkel, A.I., Henle, W., Henle, G., Anvret, M., Sanal, Ö., Ersoy, F., Caglar, M., Klein, G., 1981, Epstein-Barr virus Carrying lymphoma in a patient with ataxia-telangiectasia, Br. Med. J. 282:425–427.CrossRefGoogle Scholar
  255. Sakamoto, K., Aiba, M., Katayama, I., Sullivan, J., Humphreys, R., and Purtilo, D.T., 1981, Antibodies to Epstein-Barr virus specific antigens in patients with hairy-cell leukemia, Int. J. Cancer 27:453–458.PubMedCrossRefGoogle Scholar
  256. Sawyer, R.N., Evans, A.S., Niederman, J.C., and McCollum, R.W., 1971, Prospective study of a group of Yale University freshmen. I. Occurrence of infectious mononucleosis, J. Infect. Dis. 123:263–269.PubMedCrossRefGoogle Scholar
  257. Shanmugaratnam, K., 1978, Variations in nasopharyngeal Carcinoma incidence among specific Chinese Communities (dialect groups) in Singapore, in: Nasopharyngeal Carcinoma: Etiology and Control (G. de-Thé and Y. Ito, eds.), pp. 191–198, IARC, Lyon.Google Scholar
  258. Shanmugaratnam, K., and Higginson, J., 1967, Aetiology of nasopharyngeal Carcinoma: Report on a retrospective survey in Singapore, in: Cancer of the Nasopharynx (CS. Muir and K. Shanmugaratnam, eds.), UICC Monograph Series, Vol. 1, pp. 130–137, Munksgaard, Copenhagen.Google Scholar
  259. Shanmugaratnam, K., and Sobin, L.H., 1978b, Histological typing of upper respiratory tract tumors, in: International Histological Classification of Tumors, No. 19, World Health Organization, Geneva.Google Scholar
  260. Shanmugaratnam, K., Tan, K.K., and Lee, K.W., 1967, Lymphoma of the Burkitt type in Singapore, Int. J. Cancer 2:576–580.PubMedCrossRefGoogle Scholar
  261. Shope, T., Dechairo, D., and Miller, G., 1973, Malignant lymphoma in Cotton-top marmosets following inoculation of Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 70:2487–2491.PubMedCrossRefGoogle Scholar
  262. Simons, M.J., Wee, G.B., Day, N.E., de-Thé, G., Morris, P.J., and Shanmugaratnam, K., 1974, Immuno-genetic aspects of nasopharyngeal Carcinoma. I. Difference in HL-A antigen profiles between patients and Comparison groups, Int. J. Cancer 13:122–134.PubMedCrossRefGoogle Scholar
  263. Simons, M.J., Wee, G.B., Day, N.E., Chan, S.H., Shanmugaratnam, K., and de Thé, G., 1975, Immunogenetic aspects of nasopharyngeal Carcinoma (NPC). IV. Probable identification of an HL-A second antigen associated with a high risk for NPC, Lancet 1:142–143.PubMedCrossRefGoogle Scholar
  264. Simons, M.J., Wee, G.B., Goh, E.H., Chan, S.H., Shanmugaratnam, K., Day, N.E., and de Thé, G., 1976, Immunogenetic aspects of nasopharyngeal Carcinoma. IV. Increased risk in Chinese of nasopharyngeal Carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2), J. Natl. Cancer Inst. 57:977–980.PubMedGoogle Scholar
  265. Simons, M.J., Wee, G.B., Singh, D., Dharmalingham, S., Yong, N.K., Chau, J.C.W., Ho, J.H.C., Day, N.E., and De Thé, G., 1977, Immunogenetic aspects of nasopharyngeal Carcinoma. V. Confirmation of a Chinese related HLA profile (A2, Singapore 2) associated with an increased risk for nasopharyngeal Carcinoma, in: Epidemiology and Cancer Registries in the Pacific, Natl. Cancer Inst. Monogr. 47:147–151.Google Scholar
  266. Simons, M.J., Chan, S.H., Wee, G.B., Shanmugaratnam, K., Goh, E.H., Ho, J.H.C., Chau, J.C.W., Darmalingham, S., Prasad, U., Betuel, H., Day, N.E., and de-Thé, G., 1978, Nasopharyngeal Carcinoma and histocompatibility antigens, in: Nasopharyngeal Carcinoma: Etiology and Control (G. de-Thé and Y. Ito, eds.), pp. 271–282, Scientific Publication No. 20, IARC, Lyon.Google Scholar
  267. Slater, R.M., Philip, P., Badsberg, E., Behrendt, H., Hansen, N.E., and Van Heerde, P., 1979, A 14q+ Chromosome in a B-cell acute lymphocytic leukemia and in a leukemic nonendemic Burkitt’s lymphoma, Int. J. Cancer 23:639–647.PubMedCrossRefGoogle Scholar
  268. Sohier, R., 1971, Discordance au Cours de la mononucléose infectieuse entre l’élaboration des anticorps fixant le Complément avec un antigène soluble et des anticorps révélés par immunofluorescence, C. R. Acad. Sci. Ser. 272:3098–3101.Google Scholar
  269. Sohier, R., and de-Thé, G., 1978, EBNA antibodies are more useful than Complement-fixing antibody in monitoring infectious mononucleosis patients, Biomedicine 29:170–173.PubMedGoogle Scholar
  270. Sohier, R., Lenoir, G.M., and Lamelin, J.P.L., 1981, Les formes mortelles de l’infection primaire à virus d’Epstein-Barr avec ou sans mononucléose infectieuse, Ann. Med. Intern. 132:48–57.Google Scholar
  271. Sprunt, T.P., and Evans, F.A., 1920, Mononuclear leucocytosis in reaction to acute infections (in infectious mononucleosis), Bull. Johns Hopkins Hosp. 31:410–417.Google Scholar
  272. Stancek, D., and Robensky, J., 1979, Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients, Acta. Virol. (Prague) 23(2): 168–169.Google Scholar
  273. Stephens, R., Traul, K., Gaudreau, P., Teh, J., Fisher, L., and Mayyasi, S.A., 1977, Comparative studies on EBV antigens by immunofluorescence and immunoperixodase techniques, Int. J. Cancer 19:305–316.PubMedCrossRefGoogle Scholar
  274. Sullivan, J.L., Wallen, W.C., and Johnson, F.L., 1978, Epstein-Barr virus infection following bone-marrow transplantation, Int. J. Cancer 22(2): 132–135.PubMedCrossRefGoogle Scholar
  275. Sumaya, CV., 1977, Primary Epstein-Barr virus infections in Children, Pediatrics 59(1):16–21.PubMedGoogle Scholar
  276. Svedmyr, E., and fondai, M., 1975, Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis, Proc.Natl. Acad. Sci. U.S.A. 7:1622.CrossRefGoogle Scholar
  277. Svedmyr, A., Demissie, A., Klein, G., and Clifford, P., 1970, Antibody patterns in different human sera against intracellular and membrane antigen Complexes associated with Epstein-Barr virus, J. Natl. Cancer Inst. 44:595–610.PubMedGoogle Scholar
  278. Svoboda, D., Kirchner, K.R., and Shanmugaratnam, K., 1965, Ultrastructure of nasopharyngeal Carcinomas in American and Chinese patients: An application of electron microscopy to geographic pathology, Exp. Mol. Pathol. 4:189–204.CrossRefGoogle Scholar
  279. Thestrup-Pedersen, K., Esmann, V., Bisballe, S., Jensen, J.R., Pallesen, G., Hastrup, J., Madsen, M., Thorling, K., Masucci, M.G., Saedmundsen, A.K., and Ernberg, I., 1980, Epstein-Barr virus induced lymphoproliferative disorder Converting to fatal Burkitt-like lymphoma in a boy with interferon-inducible Chromosomal defect, Lancet:997–1002.Google Scholar
  280. Tischendorf, P., Shramek, G.J., Balagdas, R.C., Deinhardt, F., Knospe, W.H., Noble, G.R., and Maynard, J.E., 1970, Development and persistence of immunity to Epstein-Barr virus in man, J. Infect. Dis. 122:401–409.PubMedCrossRefGoogle Scholar
  281. Tovey, M.G., Lenoir, G., and Begon-Lours, J., 1978, Activation of latent Epstein-Barr virus by antibody to human IgM, Nature (London) 276:270–272.CrossRefGoogle Scholar
  282. Trumper, P.A., Epstein, M.A., Giovanella, G.C., and Finerty, S., 1977, Isolation of infectious EB virus from epithelial tumor cells of nasopharyngeal Carcinoma, Int. J. Cancer 20:655–662.PubMedCrossRefGoogle Scholar
  283. UICC, 1974, TNM Classification of Malignant Tumors, 2nd ed., Geneva.Google Scholar
  284. University Health Physicians and PHS Laboratories, 1971, A joint investigation: Infectious mononucleosis and its relationship to EB virus antibody, Br. Med. J. 4:643–646.CrossRefGoogle Scholar
  285. USPHS Advisory Committee on Smoking and Health, 1964, PHS Publ. No. 1103, USPHS, Washington, D.C.Google Scholar
  286. Van den Berghe, H., Parloir, C., Gosseye, S., Englebienne, V., Cornu, G., and Sokal, G., 1979, Variant traslocation in Burkitt’s lymphoma, Cancer Genet. Cytogenet. 1:9–14.CrossRefGoogle Scholar
  287. Virelizier, J.L., Lenoir, G., and Griscelli, C., 1978, Persistent Epstein-Barr virus infection in a Child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion, Lancet 2:231–234.PubMedCrossRefGoogle Scholar
  288. Vonka, V., and Kutinova, L., 1973, Increase of EB virus positive cells in Cultured Burkitt lymphoma cells after short-time exposure to heat, Neoplasma 30:349–352.Google Scholar
  289. Vonka, V., Benyesh-Melnick, M., and McCombs, R.J., 1970, Antibodies in human sera to soluble and viral antigens found in Burkitt’s lymphoma and other lymphoblastoid Cell lines, J. Natl. Cancer Inst. 44:865–872.PubMedGoogle Scholar
  290. Vonka, V., Kutinova, L., Drobnik, J., and Bräuerova, J., 1972, Increase of Epstein-Barr virus positive cells in EB 3 Cultures after treatment with Cisdichloro-diammine-platinum (11), J. Natl. Cancer Inst. 48:1277–1281.PubMedGoogle Scholar
  291. Wara, W.M., Wara, D.W., Phillips, T.L., and Ammahh, A., 1975, Elevated IgA in Carcinoma of the nasopharynx, Cancer 35:1313–1315.PubMedCrossRefGoogle Scholar
  292. Williams, A.O., 1966, Hemoglobin genotypes ABO blood groups and Burkitt’s tumor, J. Med. Genet. 3:177–179.PubMedCrossRefGoogle Scholar
  293. Williams, E.H., and de-Thé, G., 1974, Familial aggregation in nasopharyngeal Carcinoma, Lancet, 2:295.PubMedCrossRefGoogle Scholar
  294. Williams, E.H., Spit, P., and Pike, M.C. 1969, Further evidence of space-time Clustering of Burkitt’s lymphoma patients in the West Nile district of Uganda, Br. J. Cancer, 23:235–246.PubMedCrossRefGoogle Scholar
  295. Williams, E.H., Day, N.E., and Geser, A., 1974, Seasonal variation in onset of Burkitt’s lymphoma in the West Nile district of Uganda, Lancet 1:19–22.CrossRefGoogle Scholar
  296. Williams, E.H., Smith, P.G., Day, N.E., Geser, A., Ellice, J., and Tukei, P., 1978, Space-time Clustering of Burkitt’s lymphoma in the West Nile district of Uganda, 1961–1975, Br. J. Cancer 37:109–122.PubMedCrossRefGoogle Scholar
  297. Wolf, H., Zur Hausen, H., and Becker, V., 1973, EB viral genomes in epithelial nasopharyngeal Carcinoma cells, Nature (London) New Biol. 244:245–257.Google Scholar
  298. World Health Organization, 1970, Mortality from malignant neoplasms, 1955–1965, Geneva.Google Scholar
  299. Wright, D.H., and Pike, P.A., 1969, Bone-marrow involvement in Burkitt’s tumor, Br. J. Haematol 15:409–416.CrossRefGoogle Scholar
  300. Wright, D.H., Schumacher, H.R., Thomas, W.J., Duval-Arnould, B.J., Creegan, W.J., Forman, D.S., Strong, D.M., Robinson, J.E., and Miller, G., 1980, Polyclonal B Cell lymphoma during infection with Epstein-Barr virus (letter to editor), N. Engl. J. Med. 303(18):1064–1065.PubMedCrossRefGoogle Scholar
  301. Wu, C.H., 1921, in: The Encyclopaedia of Chinese Medical Terms, Vol. 1, p. 756, Commercial Press, Shanghai (in Chinese).Google Scholar
  302. Zech, L., Haglund, U., and Nilsson, K., 1976, Characteristic Chromosomal abnormalities in biopsies and lymphoid Cell lines from patients with Burkitt and non-Burkitt lymphomas, Int. J. Cancer 17:47.PubMedCrossRefGoogle Scholar
  303. Zeng, Y., Shang, M., Liu, C.R., Cheng, Y.H., Ou, R.S., Li, X.H., Gan, B.W., Hu, M.G., Chen, M., He, S.Q., and Mu, G.P., 1979, Detection of IgA antibody to EB virus VCA from patients with nasopharyngeal Carcinoma by immunofluorescent test, Chin. J. Oncol. 1:81–83.Google Scholar
  304. Zeng, Y., Liu, Y.X., Liu, C.R., Chen, S.W., Wei, J.N., Zhu, J.S., and Zai, H.J., 1980a, Application of an immunoenzymatic method and an immunoautoradiographic method for a mass survey of nasopharyngeal Carcinoma, Intervirology 13:162–168.CrossRefGoogle Scholar
  305. Zeng, Y., Pi, G.H., and Zhao, W.P., 1980b, Detection of EBNA by anticomplement immunoenzymatic method, Acta Acad. Med. Sin. 2:134–135.Google Scholar
  306. Ziegler, J.L., 1972, Chemotherapy of Burkitt’s lymphoma, Cancer 30:1534–1540.PubMedCrossRefGoogle Scholar
  307. Ziegler, J.L., 1977, Treatment results of 54 American patients with Burkitt’s lymphoma are similar to the African experience, N. Engl. J. Med. 297:75–80.PubMedCrossRefGoogle Scholar
  308. Ziegler, J.L., Bluming, A.Z., Morrow, R.H., Fass, L., and Carbone, P.P., 1970, Central nervous system involvement in Burkitt’s lymphoma, Blood 36:718–728.PubMedGoogle Scholar
  309. Ziegler, J.L., Andersson, M., Klein, G., and Henle, W., 1976, Detection of Epstein-Barr virus DNA in American Burkitt’s lymphoma, Int. J. Cancer 17:701–706.PubMedCrossRefGoogle Scholar
  310. Zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P., and Santesson, L., 1970, EBV DNA in biopsies of Burkitt’s tumors and anaplastic Carcinomas of the nasopharynx, Nature (London) 228:1056–1058.CrossRefGoogle Scholar
  311. Zur Hausen, H., O’Neill, F.J., Freese, U.K., and Hecher, E., 1978, Persisting oncogenic herpevirus induced by tumor promotor TPA, Nature (London) 272:373–375.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Guy De-Thé
    • 1
    • 2
  1. 1.Faculty of Medicine Alexis CarrelLyonFrance
  2. 2.IRSC-CNRSVillejuifFrance

Personalised recommendations